DFCM
ABUS icon

Dark Forest Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Dark Forest Capital Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,155
Closed -$52K – 1004
2023
Q1 		$52K Buy
+17,155
New +$48.4K 0.01% 826

Other funds holding ABUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dark Forest Capital Management's ABUS Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Arbutus Biopharma (ABUS) in Q2 2023, closing a stake of 17,155 shares — an estimated $52K sold.

Dark Forest Capital Management first reported a position in ABUS in Q1 2023 and held it in 1 quarter. The position peaked at $52K in Q1 2023. 111 funds tracked by Wall St. Rank hold ABUS as of Q2 2023.

  • Dark Forest Capital Management reported no remaining Arbutus Biopharma position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 17,155 Arbutus Biopharma shares in Q2 2023, an estimated $52K.
  • Dark Forest Capital Management first reported a position in Arbutus Biopharma in Q1 2023 and held it in 1 quarter.
  • Dark Forest Capital Management's Arbutus Biopharma position peaked at $52K in Q1 2023.
  • 111 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.